JP
Jayaraj Puthen Veetil
About Jayaraj Puthen Veetil
Data last updated:
Jayaraj Puthen Veetil is a Managing Director at Pharmacon Remedies And Research Private Limited (since 2013). The company operates in Pharma. Pharmacon Remedies And Research Private Limited reported revenue of ₹85.9 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Managing Director | 31 Oct 2013 | 2013 | ₹85.9 Lakh (FY 2024) | Active |
Board colleagues of Jayaraj Puthen Veetil
| Name | DIN | Company | Designation |
|---|---|---|---|
| Joemon Thaliyath | 07748387 | Pharmacon Remedies And Research Private Limited | Director |
| Krishnankutty Narayanan Nair | 07543188 | Pharmacon Remedies And Research Private Limited | Director |
| Suresh Cherakkatil | 07750831 | Pharmacon Remedies And Research Private Limited | Director |
| Sureshkumar Chonatt | 07518178 | Pharmacon Remedies And Research Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jayaraj Puthen Veetil
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jayaraj Puthen Veetil
Jayaraj Puthen Veetil currently holds 1 directorship: Pharmacon Remedies And Research Private Limited (Managing Director, since 31 Oct 2013, revenue ₹85.9 Lakh (FY 2024)).
Jayaraj Puthen Veetil was first appointed on 31 Oct 2013 as Managing Director at Pharmacon Remedies And Research Private Limited.
The current boards of Jayaraj Puthen Veetil's companies include Joemon Thaliyath (Pharmacon Remedies And Research Private Limited), Krishnankutty Narayanan Nair (Pharmacon Remedies And Research Private Limited), Suresh Cherakkatil (Pharmacon Remedies And Research Private Limited), Sureshkumar Chonatt (Pharmacon Remedies And Research Private Limited).